The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement
Vasilios G. Athyros(Neurosciences Institute), Christos S. Mantzoros(Beth Israel Deaconess Medical Center), Απόστολος Τσάπας(Aristotle University of Thessaloniki), Όλγα Γιουλεμέ(Hippocration General Hospital), Theodore K. Alexandrides(University of Patras), Charalambos Vlachopoulos(National and Kapodistrian University of Athens), Lοukianos S. Rallidis(National and Kapodistrian University of Athens), Alexandros D. Tselepis(University of Ioannina), Christos Pitsavos(National and Kapodistrian University of Athens), Jannis Kountouras(Aristotle University of Thessaloniki), Dimitrios Richter(Athens Euroclinic), Moses Elisaf(University of Ioannina), Niki Katsiki(Neurosciences Institute), Konstantinos Tsioufis(National and Kapodistrian University of Athens), Charalambos Karvounis(AHEPA University Hospital), Εvangelos Cholongitas, Asterios Karagiannis(Hippocration General Hospital), Κωνσταντίνος Τζιόμαλος(AHEPA University Hospital), Michael Doumas(Hippocration General Hospital), John Goudevenos(University Hospital of Ioannina), Evangelos Liberopoulos(National and Kapodistrian University of Athens), Georgios Germanidis(Aristotle University of Thessaloniki), Dimitri P. Mikhailidis(Neurosciences Institute), Themistoklis Tzotzas(St. Luke's Hospital), Themistoklis G. Vasiliadis(Papageorgiou General Hospital), Vasilios Kotsis(Aristotle University of Thessaloniki), Helen Bilianou(Tzaneion General Hospital), Emmanuel S. Ganotakis(University of Crete)
Cited by 251
Related Papers
Role of leptin in the neuroendocrine response to fasting
|Nature|1996|3.1k
Adverse metabolic and cardiovascular consequences of circadian misalignment
|Proceedings of the National Academy of Sciences|2009|2.3k
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
|Diabetes Care|2022|1.9k
Obesity and cancer risk: Emerging biological mechanisms and perspectives
|Metabolism|2018|1.6k
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
|Metabolism|2018|1.2k